Stefan Hohaus

30PUBLICATIONS
213CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursNanotoxicology, health and safetyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Feb 12, 2026
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study.

Francesco Autore, Alessandra Tedeschi, Giulia Benevolo

|Dec 24, 2025
Health-Related Quality of Life and Symptom Burden in Patients with Diffuse Large B-Cell Lymphoma Before Treatment with Tafasitamab and Lenalidomide: An Ad Hoc Analysis of Italian Real-World Data from the PRO-MIND Study.

Pier Luigi Zinzani, Nicola Battaglia, Mario Lapecorella

|Dec 11, 2025
Adult Onset of Type 2 Familial Hemophagocytic Lymphohistiocytosis After SARS-CoV-2 Vaccination with an Unusual Neurological Onset: The Great Mimic.

Flaminia Bellisario, Assunta Bianco, Francesco D'Alo'

|Aug 08, 2025
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study.

Eugenio Galli, Roberta Di Blasi, Alice Di Rocco

|Jun 24, 2025
Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T.

Eugenio Galli, Roberta Di Blasi, Ilaria Pansini

Pageof 5

Frequent Collaborators

6 joint publications

Eugenio Galli

6 joint publications

Simone Ferrero

6 joint publications

Valerio De Stefano

5 joint publications

Elena Maiolo